1514P - Serum miRNA abundances discriminate imatinib-naive patients with advanced gastrointestinal stromal tumors (GIST) from those in remission on Imatinib therapy

Autor: Kosela Paterczyk, H., Paziewska, A., Kulecka, M., Karczmarski, J., Dabrowska, M., Kluska, A., Balabas, A., Piatkowska, M., Mikula, M., Rutkowski, P., Ostrowski, J.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v535-v535
Databáze: ScienceDirect